Methods Inf Med 2001; 40(03): 248-252
DOI: 10.1055/s-0038-1634161
Original Article
Schattauer GmbH

More Up-To-Date Monitoring of Long-Term Survival Rates by Cancer Registries: An Empirical Example

H. Brenner
1   Dept. of Epidemiology, German Centre for Research on Ageing, Heidelberg, Germany
,
O. Gefeller
2   Institute of Medical Informatics, Biometry and Epidemiology, University of Erlangen-Nürnberg, Erlangen, Germany
,
C. Stegmaier
3   Saarland Cancer Registry, Saarbrücken, Germany
,
H. Ziegler
3   Saarland Cancer Registry, Saarbrücken, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
07 February 2018 (online)

Abstract:

A few years ago, a new method of survival analysis, denoted period analysis, has been developed to derive more up-to-date estimates of long-term survival rates of cancer patients, but this method has rarely been applied so far. Using empirical examples from the Saarland Cancer Registry, we illustrate how seriously traditional long-term survival estimates may lag behind survival expectations of newly diagnosed cancer patients in the case of recent improvement in prognosis, and to what extent this problem may be reduced by period analysis of survival. We conclude that period analysis should be more widely used for deriving more up-to-date long-term survival estimates.

 
  • REFERENCES

  • 1 Berrino F, Sant M, Verdecchia A. et al., eds. Survival of cancer patients in Europe. The EUROCARE Study. IARC Scientific Publication 132. Lyon: IARC; 1995
  • 2 Berrino F, Capocaccia R, Estève J. Survival of cancer patients in Europe: The EUROCARE-2 Study. IARC Scientific Publication 151. Lyon: IARC; 1999
  • 3 Wingo PA, Gloeckler Ries LA, Parker SL. et al. Long-term cancer patient survival in the United States. Cancer Epidemiol Bio-markers & Prev 1998; 7: 271-82.
  • 4 Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chron Dis 1958; 8: 699-712.
  • 5 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-64.
  • 6 Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer 1996; 78: 2004-10.
  • 7 Waterhouse J, Muir C, Shanmugaratnam K. et al., eds. Cancer incidence in five continents. Volume IV. IARC Scientific Publication 42. Lyon: IARC; 1982
  • 8 Muir C, Waterhouse J, Mack T. et al., eds. Cancer incidence in five continents. Volume V. IARC Scientific Publication 88. Lyon: IARC; 1988
  • 9 Parkin DM, Muir CS, Whelan SL. et al., eds. Cancer incidence in five continents. Volume VI. IARC Scientific Publication 120. Lyon: IARC; 1992
  • 10 Parkin DM, Whelan SL, Ferlay J. et al., eds. Cancer incidence in five continents. Volume VII. IARC Scientific Publication 143. Lyon: IARC; 1997
  • 11 Brenner H, Stegmaier C, Ziegler H. Estimating completeness of cancer registration in Saarland/Germany with capture-recapture methods. Eur J Cancer 1994; 30A: 1659-63.
  • 12 Bjørge T, Engeland A, Hansen S. et al. Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1994 and 1993. Int J Cancer 1998; 75: 663-70.
  • 13 Greenwood M. A report on the natural duration of cancer. London: Ministry of Health; His Majesty’s Stationery Office 1926
  • 14 Brenner H, Gefeller O. Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol 1997; 50: 211-6.
  • 15 Stiller CA. Population based survival rates for childhood cancer in Britain, 1980-91. BMJ 1994; 309: 1612-6.
  • 16 Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr 1961; 6: 101-21.